Urological cancer


Urological cancer trials open in South Yorkshire - includes bladder, prostate, renal and testicular cancer

All sites

MSS012
Select-d: Anticoagulation therapy in selected cancer patients at risk of recurrence of venous thromboembolism
Information from CancerHelp UK website about this trial. CancerHelp UK is a free information service about cancer and cancer care for people with cancer and their families.
Information from UK Clinical Trials Gateway website about this trial (includes main eligibility criteria, accrual & contact information)

MSS013
Add Aspirin - A phase III double-blind placebo-controlled randomised trial assessing the effects of aspirin on disease recurrence and survival after primary therapy in common non-metastatic solid tumours
Information from UK Clinical Trials Gateway website about this trial (includes main eligibility criteria, accrual & contact information)
Information from CancerHelp UK website about this trial. CancerHelp UK is a free information service about cancer and cancer care for people with cancer and their families.

MSS015
SPIRE SGI-110 to potentiate platinum response: a phase Ib/IIa open label clinical trial combining SGI-110 with cisplatin and gemcitabine chemotherapy
Information from CancerHelp UK website about this trial. CancerHelp UK is a free information service about cancer and cancer care for people with cancer and their families.
Information from UK Clinical Trials Gateway website about this trial (includes main eligibility criteria, accrual & contact information)

Bladder cancer

BLA012
POUT A phase III randomised trial of Peri-Operative chemotherapy versus sUrveillance in upper Tract urothelial cancer
Information from UK Clinical Trials Gateway website about this trial (includes main eligibility criteria, accrual & contact information)
Information from CancerHelp UK website about this trial. CancerHelp UK is a free information service about cancer and cancer care for people with cancer and their families.

BLA015
CheckMate 274 - A Phase 3 randomised, double-blind, multicentre study of adjuvant Nivolumab versus placebo in subjects with high risk invasive urothelial carcinoma
Information from UK Clinical Trials Gateway website about this trial (includes main eligibility criteria, accrual & contact information)

BLA016
CALIBER A phase II randomised feasibility study of chemoresection and surgical management in low risk non muscle invasive bladder cancer
Information from UK Clinical Trials Gateway website about this trial (includes main eligibility criteria, accrual & contact information)
Information from CancerHelp UK website about this trial. CancerHelp UK is a free information service about cancer and cancer care for people with cancer and their families.

BLA017
DANUBE A Phase III, Randomized, Open-label, Controlled, Multi-Center, Global Study of First-Line MEDI4736 Monotherapy and MEDI4736 in Combination with Tremelimumab Versus Standard of Care Chemotherapy in Patients with Unresectable Stage IV Urothelial Bladder Cancer
Information from UK Clinical Trials Gateway website about this trial (includes main eligibility criteria, accrual & contact information)

BLA018
BRAVO High grade Bladder cancer: A randomised controlled trial of Radical Cystectomy against intra-vesical immunotherapy. Understanding patients and health professionals beliefs about the two interventions and potential barriers to recruitment
Information from UK Clinical Trials Gateway website about this trial (includes main eligibility criteria, accrual & contact information)
HRA summary of this study


Prostate cancer

PRS010
STAMPEDE Systemic therapy in advancing or metastatic prostate cancer: evaluation of drug efficacy
Information from UK Clinical Trials Gateway website about this trial (includes main eligibility criteria, accrual & contact information)
Information from CancerHelp UK website about this trial. CancerHelp UK is a free information service about cancer and cancer care for people with cancer and their families.

PRS015
RADICALS: Radiotherapy and Androgen Deprivation in combination after local surgery: A randomised controlled trial for patients with prostate cancer
Information from UK Clinical Trials Gateway website about this trial (includes main eligibility criteria, accrual & contact information)
Information from CancerHelp UK website about this trial. CancerHelp UK is a free information service about cancer and cancer care for people with cancer and their families.

PRS018
ProMPT - Molecular mechanisms of disease progression and the development of novel treatment strategies in advanced prostate cancer (Northern Prostate Cancer Collaborative)
Information from UK Clinical Trials Gateway website about this trial (includes main eligibility criteria, accrual & contact information)
Information from CancerHelp UK website about this trial. CancerHelp UK is a free information service about cancer and cancer care for people with cancer and their families.

PRS025
PROMPTS A prospective randomised phase III study of observation versus screening MRI and pre-emptive treatment in castrate resistant prostate cancer patients with spinal metastasis
Information from UK Clinical Trials Gateway website about this trial (includes main eligibility criteria, accrual & contact information)
Information from CancerHelp UK website about this trial. CancerHelp UK is a free information service about cancer and cancer care for people with cancer and their families.

PRS032
ARMOR3-SV A Phase 3, randomised, open label, multicentre, controlled study of Galeterone compared to Enzalutamide in men expressing androgen receptor splice variant-7 mRNA (AR-V7) metastatic (M1) castrate resistant prostate cancer (CRPC)
Information from UK Clinical Trials Gateway website about this trial (includes main eligibility criteria, accrual & contact information)
Information from ClinicalTrials.gov about this trial

PRS033
ATLAS - A randomised, double blind, placebo-controlled Phase 3 study of JNJ-56021927 in subjects with high-risk, localised or locally advanced prostate cancer receiving treatment with primary radiation therapy
Information from UK Clinical Trials Gateway website about this trial (includes main eligibility criteria, accrual & contact information)

PRS034
PART - A randomised controlled trial of Partial prostate Ablation versus Radical prosTatectomy (PART) in intermediate risk unilateral clinically localised prostate cancer.
Information from UK Clinical Trials Gateway website about this trial (includes main eligibility criteria, accrual & contact information)
Information from CancerHelp UK website about this trial. CancerHelp UK is a free information service about cancer and cancer care for people with cancer and their families.

PRS035
VANCE A randomised phase I study to determine the safety and immunogenicity of ChAd-MVA vaccination compared to MVA alone with and without low dose cyclophosphamide in low and intermediate risk localised prostate cancer
Information from UK Clinical Trials Gateway website about this trial (includes main eligibility criteria, accrual & contact information)

XXX091
IMPACT Identification of Men with a genetic predisposition to ProstAte Cancer: Targeted Screening in BRCA1/2 mutation carriers and controls
Information from UK Clinical Trials Gateway website about this trial (includes main eligibility criteria, accrual & contact information)
Information from CancerHelp UK website about this trial. CancerHelp UK is a free information service about cancer and cancer care for people with cancer and their families.

XXX126
UK Genetic Prostate Study
Information from UK Clinical Trials Gateway website about this trial (includes main eligibility criteria, accrual & contact information)
Information from CancerHelp UK website about this trial. CancerHelp UK is a free information service about cancer and cancer care for people with cancer and their families.

MSS008
SarCaBon A randomised double-blind phase II trial of saracatinib versus placebo for cancer-induced bone pain
Information from UK Clinical Trials Gateway website about this trial (includes main eligibility criteria, accrual & contact information)
Information from CancerHelp UK website about this trial. CancerHelp UK is a free information service about cancer and cancer care for people with cancer and their families.

XXX176
PANTERA Exercise training as a novel primary therapy for men with localised prostate cancer
Information from UK Clinical Trials Gateway website about this trial (includes main eligibility criteria, accrual & contact information)

Renal cancer

REN021
STAR Standard versus modified sunitinib treatment in renal cancer: A randomised multi-stage phase 2/3 trial of sunitinib comparing temporary cessation with allowing continuation, at the time of maximal radiological response, in the first-line treatment of locally advanced and/or metastatic renal cancer
Information from UK Clinical Trials Gateway website about this trial (includes main eligibility criteria, accrual & contact information)
Information from CancerHelp UK website about this trial. CancerHelp UK is a free information service about cancer and cancer care for people with cancer and their families.

Testicular cancer / germ cell tumour